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Abstract
The ability of clodronate-containing liposomes to deplete lymph nodes of macrophages was used as a tool to investigate
 .the fate of liposomes in regional lymph nodes after subcutaneous s.c. administration. Reduced lymph node localization of
liposomes in macrophage-depleted lymph nodes confirmed that phagocytosis by macrophages plays an important role in
lymph node retention of liposomes. Depletion of macrophages had less effect on lymph node localization of small
liposomes than on the lymph node localization of large liposomes. Inclusion of distearoylphosphatidylethanolamine
 .  .  .DSPE –poly ethyleneglycol PEG–PE into the liposomes, which is known to oppose macrophage uptake, did not affect
lymph node localization in macrophage-depleted or control lymph nodes. We conclude that PEG-liposomes retained by
lymph nodes are also taken up by lymph node macrophages. Morphological observations visualizing the uptake of
PEG-liposomes by lymph node macrophages support this conclusion. q 1998 Elsevier Science B.V.
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1. Introduction
Following interstitial administration, large
molecules and colloids which are too large to enter
blood capillaries can be taken up by the lymphatic
system. The ability of the lymphatics to take up
colloids from interstitial spaces has been exploited
for the targeting of drug carriers to the lymphatic
system. In particular, liposomes, being versatile, well
w xtolerated, biodegradable lipid vesicles 1 , have re-
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ceived considerable interest as vehicles for drug tar-
 .geting to the lymphatic system. Subcutaneous s.c.
injection has been the route of administration most
extensively investigated for this purpose.
Following lymphatic uptake, liposomes pass
through a system of lymphatic vessels and will en-
counter one or more lymph nodes where a fraction
will be retained. It has been suggested that phago-
cytosis by macrophages is one of the major mecha-
nisms of uptake of colloidal particles in lymph nodes
w x2,3 . Recently, it was observed that an increase in
liposome size and the presence of phosphatidylserine
 .PS in the liposomal bilayers substantially enhanced
lymph node localization, supporting the hypothesis
that macrophage uptake is the major mechanism in-
w xvolved in lymph node localization of liposomes 4 .
However, on the other hand, coating of small 0.1
.  .  .mm liposomes with poly ethyleneglycol PEG ,
w xwhich has proven to oppose macrophage uptake 5,6 ,
hardly affected lymph node localization, suggesting
that phagocytosis by macrophages is not the only
mechanism involved in lymph node retention of lipo-
w xsomes 7 .
The aim of the present study was to investigate the
fate of liposomes in regional lymph nodes after s.c.
administration in more detail. The ability of clo-
dronate-containing liposomes to deplete macrophages
in lymph nodes was used as a tool to investigate the
localization of intranodal liposomes. Macrophages in
regional lymph nodes were depleted by s.c. adminis-
w xtration of clodronate-containing liposomes 8,9 . Lo-
 .calization of s.c. administered large nonsized and
 .small 0.1 mm liposomes was studied in lymph
nodes depleted of macrophages and compared with
 .localization in control nondepleted lymph nodes.
Sterically stabilized liposomes containing the lipid
derivative distearoylphosphatidylethanolamine
 .  .  .DSPE –PEG PEG–PE PEG-liposomes were also
included in this study. The study of PEG-liposomes
was of interest as they are known to be able to resist
phagocytosis by cells of the mononuclear phagocyte
 . w xsystem MPS 10 . Therefore, less effect of lymph
node macrophage depletion was expected in the case
of PEG-liposomes. In order to visualize liposomes in
regional lymph nodes, liposomes containing colloidal
gold were prepared and their localization in regional
lymph nodes was examined by light microscopy and
transmission electron microscopy.
2. Material and methods
2.1. Chemicals
 .Egg-phosphatidylcholine EPC and egg-phos-
 .phatidylglycerol EPG were donated by Lipoid
 .Ludwigshafen . PEG–PE was obtained from Avanti
 .  .Polar Lipids Alabaster, AL, USA . 1a , 2a n -
w 3 x H -Cholesteryloleylether spec. act. 1.71
.TBqrmmol was supplied by Amersham
 .  .Buckinghamshire, UK . Tetrachloroauric III acid
 .  .  .HAuCl , cholesterol Chol , 4- 2-hydroxyethyl -1-4
 .piperazine-ethane-sulphonic acid HEPES and di-
 .aminobenzidine-tetrahydrochloride DAB were ob-
 .tained from Sigma Chemical St. Louis, MO, USA .
 .Dichloromethylene-bisphosphonate clodronate was
a gift of Boehringer Mannheim. Hionic Fluor,
Soluene-350 and Plasmasol were purchased from
 .Packard Instruments Downers Grove, IL, USA . All
other reagents were of analytical grade.
2.2. Preparation of clodronate-containing liposomes
Clodronate-liposomes were prepared as described
w xby Van Rooijen and Sanders 8 . Briefly, a mixture of
 .EPC and Chol molar ratio 6:1 in chloroform was
evaporated to dryness by rotation under reduced pres-
sure. The lipid film was dispersed by gentle rotation
at room temperature in an aqueous solution contain-
 .ing clodronate 0.25 grml and kept at room temper-
ature for about 2 h under nitrogen. The resulting
  ..liposome dispersion about 14 mM total lipid TL
was gently shaken and sonicated for 3 min. Nonen-
capsulated clodronate was removed by centrifugation
 .of the liposomes 10,000=g, 15 min . Liposomes
were washed 2–3 times by centrifugation 25,000=
.g, 30 min using sterile phosphate buffered saline pH
7.4 PBS; 3.6 mM KH PO , 6.4 mM Na HPO , 1452 4 2 4
.mM NaCl and finally resuspended in sterile PBS and
stored under nitrogen at 48C until further use. The
final liposome suspension typically contained about
27 mM TL and about 5 mgrml clodronate.
2.3. Preparation of radiolabeled liposomes
Lymph node localization of liposomes was studied
 .utilizing the following four liposome types: 1 large,
 . nonsized EPC:EPG:Chol molar ratio 10:1:4 large
.  .  . liposomes , 2 small 0.1 mm EPC:EPG:Chol molar
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.  .  .ratio 10:1:4 small liposomes , 3 large, nonsized
 . EPC:EPG:Chol:PEG–PE molar ratio 10:1:4:1 large
.  .  .PEG-liposomes , and 4 small 0.1 m m
 . EPC:EPG:Chol:PEG–PE molar ratio 10:1:4:1 small
.PEG-liposomes . Liposomes were radiolabeled with a
w3 xtracer amount of H -labeled cholesteryloleylether
which has proven to be a reliable label to monitor the
w xfate of liposomes in vivo 11,12 . Radiolabeled lipo-
w xsomes were prepared by the thin-film method 13 . A
mixture of the appropriate amounts of lipids, includ-
w3 xing the H -label, was dissolved in a mixture of
 .chloroformrmethanol 4:1 vrv and evaporated to
dryness by rotation under reduced pressure at 408C.
After flushing the lipid film with nitrogen for at least
20 min, the film was hydrated in a sterile
HEPESrglucose-buffer pH 7.4 10 mM HEPES, 1
. mM EDTA, 270 mM glucose . Small liposomes 0.1
.mm were prepared by extruding the liposome disper-
sion sequentially through two stacked 0.1-mm and
two stacked 0.05-mm polycarbonate membrane filters
 .Nuclepore; Costar, Cambridge, MA, USA under
nitrogen pressure. Radioactivity of the radiolabeled
liposomes was assayed in Hionic Fluor as a scintilla-
tion mixture with a Philips PW4700 liquid scintilla-
tion counter. The lipid concentration in the final
liposome dispersion was about 30 mM TL.
2.4. Preparation of colloidal gold containing lipo-
somes
To study lymph node localization of liposomes by
light microscopy and transmission electron mi-
croscopy, colloidal gold-containing liposomes gold-
.liposomes were prepared. The following four lipo-
 .some types were used: 1 large EPC:EPG:Chol
 .  .  .molar ratio 10:1:4 large gold-liposomes , 2 small
 .  . 0.1 mm EPC:EPG:Chol molar ratio 10:1:4 small
.  .gold-liposomes , 3 large EPC:EPG:Chol:PEG–PE
 .  .molar ratio 10:1:4:1 large PEG–gold-liposomes
 .  .and 4 small 0.1 mm EPC:EPG:Chol:PEG–PE
 .  .molar ratio 10:1:4:1 small PEG–gold-liposomes .
Gold-liposomes were prepared as described by Hong
w xet al. 14 , with some modifications. Briefly, the
appropriate amounts of lipids, dissolved in a mixture
 .of chloroformrmethanol 4:1 vrv , were evaporated
to dryness by rotation under reduced pressure at
408C. The lipid film was dissolved in cyclohexane
and freeze dried overnight. The freeze-dried lipids
were hydrated in a freshly prepared gold
chloridercitrate solution 7.3 mM HAuCl , 27 mM4
.trisodium citrate and 2.5 mM dipotassium carbonate
at 48C. The resulting liposome dispersion 30 mM
.TL was sized by extrusion at 48C under nitrogen
pressure. Large gold-liposomes were prepared by ex-
truding twice through two stacked 1mm polycarbon-
 .ate membrane filters. Small gold-liposomes 0.1 mm
were prepared by extruding sequentially through two
stacked 0.1-mm and two stacked 0.05-mm polycar-
bonate membrane filters. Immediately after extrusion,
the formation of colloidal gold was induced by incu-
bating the liposome suspension at 378C for 30 min.
Free gold particles were removed by applying the
gold-liposome dispersion onto a Sephacryl S-1000 SF
 .column Pharmacia, Woerden, The Netherlands and
subsequent elution with HEPESrNaCl buffer pH 7.4
 .10 mM HEPES, 135 mM NaCl . The lipid concen-
tration in the final liposome dispersion ranged be-
tween 5 and 15 mM TL. Encapsulation of colloidal
gold into liposomes was examined by staining the
liposome dispersion with a 2% phosphotungstic acid
solution or a 1% uranylacetate solution for 30 s on a
freshly glow-discharged carbon grid. Electron micro-
scopic evaluation confirmed the absence of ‘free’
colloidal gold particles in the colloidal gold-contain-
ing liposome dispersions. Moreover, more than half
of the visualized liposomes contained one or more
colloidal gold particles.
2.5. Characterization of liposomes
Mean particle size was determined by dynamic
light scattering at 258C with a Malvern 4700 system
 .using a 25-mW He–Ne laser NEC, Tokyo, Japan
and the automeasure version 3.2 software Malvern,
.Malvern, UK . For viscosity and refractive index,
values of the appropriate aqueous medium were used.
As a measure of particle size distribution of the
dispersion, the system reports a polydispersity index.
This index ranges from 0.0 for an entirely mono-
disperse up to 1.0 for a polydisperse dispersion. Lipid
phosphate concentration was determined by the col-
w xorimetric method of Rouser et al. 15 .
2.6. Animal experiments
 .Male Wistar rats U:WU, CPB from the animal
facility of Utrecht University with an average weight
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of 200–250 g were used. Animals received standard
laboratory chow and water ad libitum. To eliminate
w xmacrophages in the popliteal lymph nodes 16 , rats
were injected with clodronate-liposomes 0.6 mg clo-
.dronate, 3 mmol TL into the footpad and the dorsal
side of the right foot. The extent of macrophage
depletion was assessed by immunoperoxidase stain-
ing and acid phosphatase staining as described below.
The influence of depletion of lymph node
macrophages on the extent of localization in the
popliteal lymph node of s.c. injected radiolabeled
liposomes was investigated 6 days after treatment
with clodronate-liposomes. Rats were injected s.c.
w3 x with a single dose of H -labeled liposomes 3 mmol
. TL into the dorsal side of the right foot pretreat-
. ment with clodronate-liposomes and left foot con-
.trol, i.e., no pretreatment with clodronate-liposomes .
A blood sample was drawn from the tail vein 7 h
post-injection. At this time-point peak blood levels
w xare to be expected, as determined previously 4 . At
the end of the observation period i.e., 24 h post-in-
.jection , rats were killed by cervical dislocation and
 .the site of s.c. injection i.e., the whole foot , the
popliteal lymph nodes and blood were collected.
To visualize the localization of liposomes in
popliteal lymph nodes by light and transmission elec-
tron microscopy, rats were s.c. injected into the dor-
sal side of the foot with gold-liposomes. Rats re-
ceived large gold-liposomes, large PEG–gold-lipo-
somes, small gold-liposomes or small PEG–gold-
 .liposomes about 3 mmol TL . About 6 h post-injec-
tion, rats were killed by cervical dislocation and
popliteal lymph nodes were collected.
2.7. Assessment of degree of macrophage depletion
The effect of macrophage depletion treatment was
assessed by subjecting sections of popliteal lymph
 .nodes to the following staining procedures: A im-
munoperoxidase staining using an monoclonal anti-
body directed against rat lymph node macrophages,
 .  .and B acid phosphatase staining. A Immunoperox-
 .idase staining: cryostat sections 8–10 mm of
popliteal lymph nodes were fixed on slides with
acetone and air-dried. Slides were incubated for 60
min with monoclonal antibody ED3, which binds
specifically to medullary and subsinusoidal
w xmacrophages in the outer cortex 17 . After washing
three times with PBS the slides were incubated for 30
min with peroxidase-conjugated rabbit anti-rat im-
munoglobulin in PBSrBSA 0.5% Daka, Copen-
.hagen, Denmark containing 1% normal rat serum.
Slides were then rinsed three times with PBS and
peroxidase-activity was determined with 0.5 mg
DABrml in 0.05 M Tris buffer pH 7.6 containing
0.01% hydrogen peroxide for 10–15 min. After
washing in 0.9% NaCl, staining was intensified by
 .incubation with a CuSO solution 5 mgrml in 0.9%4
NaCl for 15 min. After washing, sections were counter
stained with haematoxylin for 15 s, dehydrated and
mounted in malinol. Control slides were incubated
with PBSrBSA 0.5% in the first step, instead of the
 .monoclonal antibody solution. B Acid phosphatase
 .staining: cryostat sections 8–10 mm of popliteal
lymph nodes were fixed with acetone and air dried.
Acid phosphatase was determined, using naphtol-AS-
w xMX-phosphate as a substrate 18 with hexazotized
w xpararosaniline as diazonium salt 19 and counter
stained with haematoxylin for 15 s, dehydrated and
mounted in malinol.
2.8. Radioacti˝ity measurements
 .Radioactivity in blood samples 120 ml was de-
termined by adding 120 ml of Plasmasol, 500 ml of
Fig. 1. Effect of pretreatment with liposomal clodronate on
lymphatic uptake of s.c. administered liposomes. Macrophages in
regional popliteal lymph nodes were eliminated by s.c. injection
of clodronate-liposomes. Some 6 days after pretreatment with
 .liposomal clodronate, rats were s.c. injected with large nonsized
 .or small 0.1 mm radiolabeled liposomes into the right foot
 .  .pretreated with clodronate and left foot control . Recovery of
liposomal label from the s.c. injection site was determined 24 h
post-injection. Values represent the mean percentage of injected
 .dose remaining at the s.c. injection site "sd of six animals .
)p-0.05.
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Fig. 2. Effect of depletion of lymph node macrophages on lymph
node localization of s.c. administered liposomes. Macrophages in
regional popliteal lymph nodes were eliminated by s.c. injection
of clodronate-liposomes. Some 6 days after pretreatment with
liposomal clodronate, rats were s.c. injected with radiolabeled
 .liposomes into the right foot pretreated with clodronate and left
 .foot control . Localization of liposomal label was determined 24
 .  .h post-injection. A Lymph node localization of large nonsized
 .  .liposomes. B Lymph node localization of small 0.1 mm
liposomes. Values represent the mean percentage of injected dose
 .per gram tissue in popliteal lymph nodes "sd of six animals .
Note the differences in scale of the y-axes. )p-0.05.
water and 500 ml of 35% hydrogen peroxide. The
samples were decolorized overnight at 408C. Ra-
dioactivity was assayed in Plasmasol as a scintillation
fluid. A total blood volume per rat of 75 mlrkg body
weight was used for calculation of the percentage
w xinjected dose in the blood circulation 20,21 . Lymph
nodes and feet were solubilized completely in an
appropriate amount of Soluene-350 at 408C. Solubi-
 .lized lymph nodes and samples 500 ml of solubi-
lized foot were decolorized with 200 ml of 35%
hydrogen peroxide overnight at 408C. Radioactivity
of the decolorized samples was assayed in Hionic
Fluor as scintillation fluid.
Lymphatic uptake is defined as the percentage
 .  .injected dose %ID radioactivity i.e., 100% minus
the percentage of dose radioactivity recovered from
the injection site. Lymph node localization is ex-
pressed as the percentage of injected dose of radioac-
 .tivity per gram lymph node popliteal tissue
 .%IDrg . Results represent the mean of 6 rats"
 .standard deviation sd .
2.9. Light and electron microscopy
Localization of gold-liposomes in regional lymph
nodes was studied by light microscopy of silver-en-
hanced semi-thin sections and transmission electron
microscopy. Popliteal lymph nodes of rats injected
with gold-liposomes were fixed in a 2% solution of
glutaraldehyde in PBS. The samples were then pro-
cessed for resin histology, employing post-fixation in
buffered osmium tetraoxide, alcohol dehydration and
embedding in Epon 812 epoxy resin. For electron
microscopy some tissue blocks were stained en bloc
with 1% p-phenylenediamine in 70% alcohol to en-
hance lipid visualization. For light microscopy, 1-mm
sections were cut on a LKB III Ultratome LKB
.Producter, Stockholm, Sweden and mounted on glass
slides. The gold particles were enhanced using an
Intensee, M silver enhancement kit RPN 491
 .Amersham International, Buckinghamshire, UK and
the sections were stained with 1% toluidine blue and
Fig. 3. Effect of surface modification with PEG on blood levels
of s.c. administered liposomes. Macrophages in popliteal lymph
nodes were eliminated by s.c. injection of clodronate-liposomes.
Six days after pretreatment with liposomal clodronate, rats were
 .  .s.c. injected with large nonsized or small 0.1 mm radiolabeled
 .liposomes into the right foot pretreated with clodronate and left
 .foot control . Recovery of liposomal label in blood was deter-
mined 7 h and 24 h post-injection. Values represent the mean
percentage of injected dose circulating in the blood "sd of six
.animals .
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Fig. 4. Lightmicrograph of 1 mm resin silver-enhanced section of a popliteal lymph node isolated 6 h after s.c. injection of small 0.1
.  .  .mm gold-liposomes composed of EPC:EPG:Chol molar ratio 10:1:4 into the foot. Paracortical sinus; macrophages large arrows and
 .endothelial cells small arrows containing colloidal gold particles.
basic fuchsin. The sections were examined using a
Zeiss Axioplane light microscope Oberkochen, Hert-
.fordshire, UK using polarized light. Following light
microscopy, the resin specimen blocks were trimmed
and 70–90 nm sections of the selected area of the
lymph nodes were cut. The sections were collected
Fig. 5. Transmission electron micrographs of 70–90 nm resin section of a popliteal lymph node isolated 6 h after s.c. injection of small
 .  .  .  .0.1 mm gold-liposomes composed of EPC:EPG:Chol molar ratio 10:1:4 into the foot. A Macrophage M containing colloidal gold
 .  .  .near endothelial cell EC . B Enlargement of A; intracellular vesicles containing colloidal gold particles arrows .
( )C. Oussoren et al.rBiochimica et Biophysica Acta 1370 1998 259–272 265
( )C. Oussoren et al.rBiochimica et Biophysica Acta 1370 1998 259–272266
on G200 copper grids and stained with aqueous
uranyl acetate and lead citrate Reichert Ultrastainer;
.Leica, Rijswijk, The Netherlands before examination
at an accelerating voltage of 60 kV in a Philips
EM201 transmission electron microscope Philips
Analytical, Electron Optics, Eindhoven, The Nether-
.lands . The lightmicrographs and the transmission
electron micrographs shown should be considered as
typical examples of the evaluated sectioned material.
2.10. Statistics
The effect of different treatments was compared by
a two-tail Student’s t-test assuming equal variances
with 95% confidence interval. Differences were con-
sidered significant when the p-value was less than
0.05.
3. Results
3.1. Effect of macrophage depletion on degree of
lymph node localization of liposomes
Lymph node localization of four types of lipo-
somes, composed of EPC:EPG:Chol molar ratio
.   ..10:1:4 differing in size large and small 0.1 mm
 .with or without PEG–PE 6 mol% , was compared.
Liposomes were radiolabeled with a trace amount of
w3 xH -cholesteryloleylether. Lymph node localization
of radiolabeled liposomes was determined in popliteal
lymph nodes depleted of macrophages and in control
 .nondepleted lymph nodes derived from the contra-
lateral side of the body. The so-called macrophage
‘suicide technique’ was used to deplete popliteal
w xlymph nodes of macrophages 9 . S.c. injection of
clodronate-liposomes results in depletion of
macrophages lining the subcapsular sinus and those
w xin the medulla of regional popliteal lymph nodes 22 .
To determine the effectiveness of the liposomal clo-
dronate-treatment, the degree of macrophage deple-
tion was assessed. The extent of macrophage deple-
tion was studied 6 days after s.c. injection of clo-
dronate-containing liposomes. This time-point was
considered appropriate for performing the lymph node
localization experiments as elimination of
macrophages in popliteal lymph nodes after s.c. ad-
ministration of clodronate-liposomes in the footpad
of mice was found to be completed 5 days post-injec-
tion; repopulation was not observed within 1 month
w xafter treatment 22 . Immunoperoxidase staining re-
vealed that in popliteal lymph nodes draining the s.c.
injection site of clodronate-liposomes, macrophages
in the medulla and the subcapsular sinuses were
completely eliminated. Few macrophages were still
present in the paracortical area as revealed by acid
phosphatase staining. Macrophages in the contra-
lateral popliteal lymph nodes were not affected re-
.sults not shown .
Some 6 days after s.c. administration of clo-
dronate-liposomes, radiolabeled liposomes were in-
 .jected s.c. into the dorsal side of the right pretreated
 .and left control foot. Lymphatic uptake from the
s.c. injection site and lymph node localization were
determined 24 h post-injection.
Fig. 1 presents the %ID remaining at the s.c.
injection site. Lymphatic uptake of the larger lipo-
some types was low compared to uptake of the small
liposome types about 98 and 40%ID remaining at
.the injection site, respectively . Pretreatment with
clodronate-liposomes had practically no effect on
lymphatic uptake of the various liposome types inves-
tigated; a slight negative effect was observed only in
case of the two small liposome types. The effect of
inclusion of PEG-PE on the lymphatic uptake of
small and large liposomes was negligible regardless
 .of prior treatment with clodronate-liposomes Fig. 1 .
Lymph node localization of large, nonsized lipo-
somes in nondepleted, control lymph nodes and lymph
nodes depleted of macrophages is presented in Fig.
 .2A. About 46%IDrg i.e. 0.2%ID was recovered
from the control lymph nodes 24 h after injection of
nonsized, large liposomes. Depletion of macrophages
resulted in a drastically decreased lymph node local-
 .ization of large liposomes 87% reduction . Inclusion
of PEG–PE did not influence lymph node localiza-
tion of large liposomes in macrophage-depleted and
 .control nondepleted lymph nodes. The effect of
Fig. 6. Transmission electron micrographs of 70–90 nm resin section of a popliteal lymph node isolated 6 h after s.c. injection of large
 .  .  .PEG–gold-liposomes composed of EPC:EPG:Chol:PEG–PE molar ratio 10:1:4:1 into the foot. A Macrophage M in lymph node
 .  .sinus. B Enlargement of A; intracellular vesicles containing colloidal gold particles arrows .
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Fig. 8. Transmission electron micrographs of 70–90 nm resin section of a popliteal lymph node isolated 6 h after s.c. injection of large
 .  .  .PEG–gold-liposomes composed of EPC:EPG:Chol:PEG–PE molar ratio 10:1:4:1 into the foot. A Endothelial cell EC lining lymph
 .  .  .node sinus LNS . B Enlargement of A; Intracellular vesicles containing colloidal gold particles arrows .
macrophage depletion on lymph node localization of
 .small 0.1 mm liposomes is shown in Fig. 2B. About
 .160%IDrg i.e. 0.6%ID was recovered from control
the lymph nodes 24 h after injection of small lipo-
somes. Localization of small liposomes in lymph
nodes depleted of macrophages was substantially less
than in control lymph nodes. However, the effect of
depletion was less as compared to the effect on
localization of large liposomes 59% vs. 87% reduc-
.tion, respectively . No significant effect of the pres-
ence of PEG–PE on liposome localization in
macrophage-depleted and control lymph nodes was
observed. As a control, lymphatic uptake from the
s.c. injection site and lymph node localization of
large, nonsized radiolabeled liposomes was studied 6
days after pretreatment with empty liposomes i.e.,
.devoid of clodronate prepared in a similar way as
clodronate liposomes. Pretreatment with empty lipo-
somes did not affect lymphatic uptake or lymph node
 .localization of the large liposomes results not shown .
Fig. 3 shows blood levels of liposomes at 7 and 24
h after injection. Subcutaneous administration of large
liposomes yielded much lower blood levels than s.c.
administration of small liposomes at both time-points.
Inclusion of PEG–PE resulted in considerably higher
blood levels, both for large and small liposomes.
These results are in line with our earlier observations
on the pharmacokinetics of conventional liposomes
and PEG-liposomes in rats not pretreated with liposo-
w xmal clodronate 4,7 .
Fig. 7. Transmission electron micrographs of 70–90 nm resin section of a popliteal lymph node isolated 6 h after s.c. injection of small
 .  .  .  .0.1 mm PEG–gold-liposomes composed of EPC:EPG:Chol:PEG–PE molar ratio 10:1:4:1 into the foot. A Macrophage M between
  .lymphocytes in paracortex. B Enlargement of A; intracellular vesicles containing colloidal gold particles arrows .
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3.2. Microscopic obser˝ations
The different liposome types under investigation
were labeled with colloidal gold to visualize their
 .localization in control nondepleted popliteal lymph
nodes. Colloidal gold has proven to be a useful
electron-dense marker for microscopic evaluation of
w xlocalization of liposomes in vivo 14 . Typical exam-
ples of light and transmission electron microscopy
are presented. Light microscopy of silver-enhanced
semi-thin sections of popliteal lymph nodes isolated 6
h after s.c. administration of gold-liposomes revealed
an intracellular presence of liposomes. Large lipo-
somes concentrated predominantly in macrophages in
 .the subcapsular sinus results not shown . Small lipo-
somes, on the other hand, tended to localize in sinus
macrophages in the cortical and medullary sinuses
rather than in the subcapsular sinus. Endothelial cells
lining the sinuses were found to contain a high
amount of gold particles only after administration of
 .small liposomes Fig. 4 . Transmission electron mi-
croscopy confirmed macrophages as the predominant
site of liposome localization. In all cases, colloidal
 .gold was found in intracellular vesicles Fig. 5 .
Remarkably, also PEG-liposomes were found to be
localized primarily within the macrophages Figs. 6
.and 7 . Also in endothelial cells lining the lymphatic
sinuses, colloidal gold was observed in some cases
 .Fig. 8 .
4. Discussion
The main objective of the present study was to
gain more insight into the fate of liposomes in re-
gional lymph nodes after s.c. administration of lipo-
somes. Selective depletion of macrophages from vari-
ous tissues in vivo has been exploited to investigate
the role of these cells in defined biological processes
w x9 . Here, experiments were designed to study the
effect of liposomal clodronate-mediated depletion of
macrophages in lymph nodes on the intranodal local-
ization of s.c. administered liposomes. Prior to that, it
was evaluated whether treatment with clodronate-
liposomes influences the degree of lymphatic uptake
of s.c administered liposomes from the s.c. injection
site. Lymphatic uptake was only slightly affected by
 .pretreatment with clodronate-liposomes Fig. 1 .
Therefore, it is concluded that the fraction of lipo-
somes reaching the regional lymph nodes after pre-
treatment with clodronate-liposomes is about the same
to that reaching control lymph nodes. Hence, the
interpretation of the present lymph node localization
findings is not complicated by liposomal clodronate-
induced differences in degree of lymphatic uptake
from the injection site.
Pretreatment with liposomal clodronate resulted in
drastic reduction of lymph node localization of large
 .as well as small liposomes Fig. 2 . However, the
reduction in lymph node localization was substan-
 .tially higher about 1.5-fold in the case of the large
liposomes compared to the small liposomes. The
difference in degree of lymph node localization in
macrophage-depleted lymph nodes between small and
large liposomes may be related to the ability of small
liposomes to penetrate more efficiently into the nodal
tissue than large liposomes. As macrophages in the
subcapsular sinus and medulla were completely de-
pleted, clodronate-liposomes are probably phagocy-
tosed predominantly by macrophages present in these
lymph node areas. The large liposomes will likely
follow the routing of the large, clodronate-liposomes
through the lymph node and, therefore, tend to pass
through lymph node regions which are depleted from
macrophages. Consequently, phagocytosis of these
large liposomes will be strongly reduced. Considering
the finding that lymph node retention is also strongly
 .reduced Fig. 2A , the involvement of macrophages
for lymph node localization of large liposomes is
clearly indicated. Small liposomes, as a result of their
size, might be able to penetrate more efficiently into
deeper areas of the lymph node and may, therefore,
reach lymph node regions not encountered by the
large clodronate-liposomes. Thus, phagocytosis of
small liposomes may still occur by macrophages
present in nondepleted areas of the lymph node. A
second explanation for the difference in effect of
liposomal clodronate-treatment on lymph node local-
ization between large and small liposomes relates to
the possibility of uptake of small liposomes by cells
other than macrophages. Small liposomes may be
taken up by cells, such as endothelial cells, capable
of pinocytosis of macromolecules and very small
w xparticles 23,24 . This explanation seems in line with
the light microscopy results. Small gold-liposomes
localized to a high extent in sinus macrophages, but
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colloidal gold was also observed in endothelial cells
 .lining the sinuses Fig. 5 . After administration of
large gold-liposomes, uptake in endothelial cells was
negligible. It is known that when macrophages are
eliminated, other cells may partly take over the func-
w xtion of endocytosis 25–27 . As these cells will take
up smaller particles only, the depletion treatment
exerts less effect on the localization of small lipo-
somes.
As surface modification with PEG is known to
resist phagocytosis of liposomes by macrophages, it
was anticipated that lymph node localization of
PEG-liposomes would be substantially lower as com-
pared to liposomes lacking the PEG-coating. More-
over, one would expect that the depletion of
macrophages has only a minor effect on lymph node
localization of PEG-liposomes. Surprisingly, how-
ever, we observed that inclusion of PEG–PE did not
significantly influence lymph node localization in
control and depleted lymph nodes. The presence of
PEG–PE did not affect lymph node localization in
control lymph nodes. In addition, macrophage deple-
tion also had a strong effect on the degree of localiza-
tion of PEG-liposomes. Moreover, large numbers of
colloidal gold particles were observed in macrophages
after administration of PEG–gold-liposomes by trans-
 .mission electron microscopy Figs. 7 and 8 . These
results can not be attributed to a failure to achieve
effective steric stabilization, as the PEG-liposomes
proved to be long-circulating after reaching the blood
 .circulation Fig. 3 . We hypothesize that the initial
mechanism of lymph node localization may be the
result of mechanical depth filtration in the meshwork
of reticular cells in the lymph node. Because of the
slow progression of the liposomes through the lymph
node, enough time is available for an effective inter-
action of the PEG-liposomal surface with phagocytic
cell membranes and, given enough time, even PEG-
liposomes will be taken up by macrophages. In this
context, one should realize that it is the rate, rather
than the extent of phagocytosis, that is affected by the
hydrophilic PEG-coating; macrophages of liver and
spleen still ingest a substantial part of an i.v. dose of
PEG-liposomes. Partial removal of the steric barrier
from the particle surface has been suggested to be
responsible for the observed uptake of poloxamine-
908 coated polystyrene particles by spleen
w xmacrophages 5,10,28 . However, in the view of the
relatively early observation time point 6 h post-injec-
.tion and the much stronger anchoring of PEG to the
liposomal bilayers via the hydrophobic anchor DSPE
as compared to the physically adsorbed poloxamine-
908, this possibility seems unlikely. The reason for
the apparent efficient uptake of PEG-liposomes by
lymph node macrophages remains to be investigated.
Observations on earlier time-points after injection
might reveal differences between the localization of
control and PEG-liposomes.
For treatment of diseases with lymphatic involve-
 .ment e.g., cancer, HIV , it is desirable to develop
approaches for the delivery of diagnostic and thera-
peutic agents to the diseased lymph nodes. Also,
lymphatic targeting of antigens to induce immune
responses is of interest as lymph nodes play an
important role in establishing humoral and cellular
immunity by the processing of antigens. Results pre-
sented in this paper establish that phagocytosis by
macrophages is the most important mechanism for
lymph node localization of large liposomes. Deple-
tion of macrophages had less effect on the lymph
node localization of small liposomes. Small lipo-
somes may reach macrophages in regions of lymph
nodes not reached by large liposomes. In addition,
small liposomes may be taken up by cells other than
macrophages, such as endothelial cells lining the
lymph node sinuses. Remarkably, inclusion of PEG–
PE into the liposomes did not reduce lymph node
localization in control lymph nodes. Macrophage de-
pletion had also a strong effect on the lymph node
localization of PEG-liposomes. Therefore, it is con-
cluded that PEG-liposomes retained by lymph nodes
are to a large extent taken up by lymph node
macrophages. Morphological observations visualizing
the uptake of PEG-liposomes by lymph node
macrophages support this conclusion. The results pre-
sented in this paper are relevant for the design of
liposomes for targeting of diagnostic agents, drugs
and antigens to regional lymph nodes.
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